STELLARIS PC
Posterior Capsule Opacification (PCO) prevention
Phase 3Active
Key Facts
Indication
Posterior Capsule Opacification (PCO) prevention
Phase
Phase 3
Status
Active
Company
About Harrow Health
Harrow Health is an integrated eyecare company with a mission to address unmet needs in ophthalmology through a diversified business model encompassing proprietary pharmaceuticals, non-sterile compounding, and sterile compounding. The company has achieved commercial success with several FDA-approved products and maintains a pipeline of development-stage candidates. Its strategic direction involves leveraging its ImprimisRx platform for distribution while advancing its proprietary pipeline through internal development and acquisitions.
View full company profile